{"id":"W2042093910","doi":"10.1016/j.ygyno.2005.09.032","title":"A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study","year":2005,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Regimen; Tirapazamine; Ovarian cancer; Cisplatin; Gynecologic oncology; Internal medicine; Chemotherapy; Oncology; Progressive disease; Chemotherapy regimen; Surgery; Adverse effect; Phases of clinical research; Ovarian carcinoma; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002298377,0.002075245,0.004010813,0.0008667013,0.0006038739,0.001303719,0.001817169,0.002181088,0.003559277],"category_scores_gemma":[0.001894307,0.001092774,0.002574649,0.0007734122,0.001591672,0.001403337,0.0005605919,0.003916062,0.000998725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001346926,"about_ca_system_score_gemma":0.002469445,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002669419,"about_ca_topic_score_gemma":0.004966126,"domain_scores_codex":[0.9991599,0.0004489227,0.00004012865,0.0001495382,0.00006913167,0.0001323353],"domain_scores_gemma":[0.9984539,0.000258357,0.0002809646,0.0001720366,0.00008260981,0.0007521305],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8636482,0.05615914,0.003979419,0.0006575506,0.002490249,0.0002217734,0.0003735919,0.001875986,0.02519043,0.0002118347,0.001947075,0.04324471],"study_design_scores_gemma":[0.7457976,0.2442264,0.006488366,0.00001459003,0.0007742626,0.0001496276,0.00005753313,0.0005229688,0.001101377,0.00009268738,0.0007417151,0.00003284062],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945619,0.001130596,0.0004194111,0.00040981,0.0001002502,0.00169866,0.0008781778,0.00007453321,0.0007267253],"genre_scores_gemma":[0.9880599,0.002657466,0.002133071,0.0008155234,0.0002468036,0.002383978,0.001773257,0.00006197808,0.001868009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004010813,"threshold_uncertainty_score":0.01215512,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09526104529368758,"score_gpt":0.4222465381856592,"score_spread":0.3269854928919717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}